| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |